Published in Malar J on August 20, 2013
G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. Malar J (2013) 1.40
Maintaining Specimen Integrity for G6PD Screening by Cytofluorometric Assays. J Histochem Cytochem (2015) 0.81
Cost-effectiveness analysis of rapid diagnostic tests for G6PD deficiency in patients with Plasmodium vivax malaria in the Brazilian Amazon. Malar J (2016) 0.76
Glucose-6-phosphate dehydrogenase deficiency. Lancet (2008) 8.26
The normal human female as a mosaic of X-chromosome activity: studies using the gene for C-6-PD-deficiency as a marker. Proc Natl Acad Sci U S A (1962) 3.88
G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med (2012) 2.93
G6PD deficiency: global distribution, genetic variants and primaquine therapy. Adv Parasitol (2013) 1.85
Protein synthesis in vitro by cryopreserved Plasmodium falciparum. Am J Trop Med Hyg (1975) 1.84
Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening. PLoS One (2011) 1.79
Hematologically important mutations: glucose-6-phosphate dehydrogenase. Blood Cells Mol Dis (2002) 1.76
Red blood cell preservation by droplet freezing with polyvinylpyrrolidone or sucrose-dextrose and by bulk freezing with glycerol. Transfusion (2011) 1.51
Biopreservation of red blood cells: past, present, and future. Transfus Med Rev (2005) 1.23
Evaluation of a rapid qualitative enzyme chromatographic test for glucose-6-phosphate dehydrogenase deficiency. Am J Trop Med Hyg (2010) 1.23
A novel cytofluorometric assay for the detection and quantification of glucose-6-phosphate dehydrogenase deficiency. Sci Rep (2012) 1.16
Flow cytofluorometric analysis of enzyme reactions based on quenching of fluorescence by the final reaction product: detection of glucose-6-phosphate dehydrogenase deficiency in human erythrocytes. J Histochem Cytochem (1989) 1.03
A sensitive cytochemical staining method for glucose-6-phosphate dehydrogenase activity in individual erythrocytes. I. Optimalization of the staining procedure. Histochemistry (1982) 1.02
Evaluation of glucose-6-phosphate dehydrogenase stability in blood samples under different collection and storage conditions. Clin Chem (2005) 1.02
Preservation of metabolic activity in lyophilized human erythrocytes. Proc Natl Acad Sci U S A (1992) 0.90
Post-extraction stabilization of HIV viral RNA for quantitative molecular tests. J Virol Methods (2012) 0.89
Membrane Stability during Biopreservation of Blood Cells. Transfus Med Hemother (2011) 0.83
Preparation and usefulness of frozen blood. Annu Rev Med (1985) 0.78
Point-of-care diagnostics for global health. Annu Rev Biomed Eng (2008) 4.11
Maternal malaria and gravidity interact to modify infant susceptibility to malaria. PLoS Med (2005) 2.72
A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis. Sci Transl Med (2010) 2.00
Diabetes trends among delivery hospitalizations in the U.S., 1994-2004. Diabetes Care (2010) 1.94
Compositionally and functionally distinct editosomes in Trypanosoma brucei. RNA (2006) 1.86
Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis. J Infect Dis (2012) 1.82
Identification of human T cell antigens for the development of vaccines against Mycobacterium tuberculosis. J Immunol (2008) 1.70
Natural and induced dyskinetoplastic trypanosomatids: how to live without mitochondrial DNA. Int J Parasitol (2002) 1.68
Therapeutic immunization against Mycobacterium tuberculosis is an effective adjunct to antibiotic treatment. J Infect Dis (2012) 1.62
Intradermal immunization improves protective efficacy of a novel TB vaccine candidate. Vaccine (2009) 1.58
Plasmodium falciparum: chondroitin sulfate A is the major receptor for adhesion of parasitized erythrocytes in the placenta. Exp Parasitol (2006) 1.44
G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. Malar J (2013) 1.40
Perspectives on introduction and implementation of new point-of-care diagnostic tests. J Infect Dis (2012) 1.33
Molecular architecture and mechanism of an icosahedral pyruvate dehydrogenase complex: a multifunctional catalytic machine. EMBO J (2002) 1.30
Trends in pregnancy hospitalizations that included a stroke in the United States from 1994 to 2007: reasons for concern? Stroke (2011) 1.30
Hospitalizations of pregnant HIV-infected women in the USA prior to and during the era of HAART, 1994-2003. AIDS (2006) 1.29
Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions. Am J Obstet Gynecol (2011) 1.28
A multicountry evaluation of careHPV testing, visual inspection with acetic acid, and papanicolaou testing for the detection of cervical cancer. Int J Gynecol Cancer (2014) 1.26
Solution structure, conformational dynamics, and CD4-induced activation in full-length, glycosylated, monomeric HIV gp120. J Virol (2012) 1.21
Critical proinflammatory and anti-inflammatory functions of different subsets of CD1d-restricted natural killer T cells during Trypanosoma cruzi infection. Infect Immun (2005) 1.17
An evaluation of novel, lower-cost molecular screening tests for human papillomavirus in rural China. Cancer Prev Res (Phila) (2013) 1.10
Rapid Wuchereria bancrofti-specific antigen Wb123-based IgG4 immunoassays as tools for surveillance following mass drug administration programs on lymphatic filariasis. Clin Vaccine Immunol (2013) 1.06
What should the ideal HIV self-test look like? A usability study of test prototypes in unsupervised HIV self-testing in Kenya, Malawi, and South Africa. AIDS Behav (2014) 1.04
Extended result reading window in lateral flow tests detecting exposure to Onchocerca volvulus: a new technology to improve epidemiological surveillance tools. PLoS One (2013) 1.02
Lower cost strategies for triage of human papillomavirus DNA-positive women. Int J Cancer (2013) 1.02
Prime-boost vaccination with heterologous live vectors encoding SIV gag and multimeric HIV-1 gp160 protein: efficacy against repeated mucosal R5 clade C SHIV challenges. Vaccine (2011) 1.01
Laboratory operations, specimen processing, and handling for viral load testing and surveillance. J Infect Dis (2010) 0.99
Outpatient upper respiratory tract viral infections in children with malaria symptoms in Western Kenya. Am J Trop Med Hyg (2010) 0.99
Malaria prevalence defined by microscopy, antigen detection, DNA amplification and total nucleic acid amplification in a malaria-endemic region during the peak malaria transmission season. Trop Med Int Health (2011) 0.98
Toward low-cost affinity reagents: lyophilized yeast-scFv probes specific for pathogen antigens. PLoS One (2012) 0.94
Depression, diabetes, and chronic disease risk factors among US women of reproductive age. Prev Chronic Dis (2011) 0.93
Isolate-specific differences in the conformational dynamics and antigenicity of HIV-1 gp120. J Virol (2013) 0.91
A conserved cis peptide bond is necessary for the activity of Bowman-Birk inhibitor protein. Biochemistry (2002) 0.90
Trends in hospitalizations of HIV-infected children and adolescents in the United States: analysis of data from the 1994-2003 Nationwide Inpatient Sample. Pediatrics (2007) 0.90
Field evaluation of a prototype paper-based point-of-care fingerstick transaminase test. PLoS One (2013) 0.90
Both CD1d antigen presentation and interleukin-12 are required to activate natural killer T cells during Trypanosoma cruzi infection. Infect Immun (2005) 0.90
Site-directed mutagenesis of a loop at the active site of E1 (alpha2beta2) of the pyruvate dehydrogenase complex. A possible common sequence motif. Eur J Biochem (2003) 0.89
Post-extraction stabilization of HIV viral RNA for quantitative molecular tests. J Virol Methods (2012) 0.89
Breast milk CD4+ T cells express high levels of C chemokine receptor 5 and CXC chemokine receptor 4 and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy. J Infect Dis (2007) 0.89
Epidemiology and prevention of stroke: a worldwide perspective. Expert Rev Neurother (2012) 0.88
Prevalence of self-reported high blood pressure awareness, advice received from health professionals, and actions taken to reduce high blood pressure among US adults--Healthstyles 2002. J Clin Hypertens (Greenwich) (2005) 0.87
Identification of Mycobacterium tuberculosis vaccine candidates using human CD4+ T-cells expression cloning. Vaccine (2008) 0.84
A prospective study of age trends of high-risk human papillomavirus infection in rural China. BMC Infect Dis (2014) 0.83
Children with sickle cell disease and human immunodeficiency virus-1 infection: use of inpatient care services in the United States. Pediatr Infect Dis J (2007) 0.82
Isolation of monoclonal antibodies with predetermined conformational epitope specificity. PLoS One (2012) 0.81
Use of fusion proteins and procaryotic display systems for delivery of HIV-1 antigens: development of novel vaccines for HIV-1 infection. Curr HIV Res (2003) 0.81
Hospitalizations for invasive pneumococcal disease among HIV-1-infected adolescents and adults in the United States in the era of highly active antiretroviral therapy and the conjugate pneumococcal vaccine. J Acquir Immune Defic Syndr (2010) 0.81
Hospitalizations for invasive pneumococcal disease among human immunodeficiency virus-1 infected children, adolescents and young adults in the United States in the era of highly active antiretroviral therapy and the conjugate pneumococcal vaccine. Pediatr Infect Dis J (2010) 0.76
Trends in pregnancy-related and delivery hospitalizations among HIV-infected adolescents, 1994 to 2004. J Acquir Immune Defic Syndr (2007) 0.76
Parasite-induced chronic inflammation is not exacerbated by immunotherapy before or during Trypanosoma cruzi Infection. Clin Vaccine Immunol (2007) 0.75
How dental team members describe adverse events. J Am Dent Assoc (2016) 0.75
Diabetes trends in hospitalized HIV-infected persons in the United States, 1994-2004. Curr HIV Res (2009) 0.75
Classifying Adverse Events in the Dental Office. J Patient Saf (2017) 0.75
The Influence of Human Papillomavirus Genotypes on Visual Screening and Diagnosis of Cervical Precancer and Cancer. J Low Genit Tract Dis (2015) 0.75